Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare Biotechnology

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.

TSX:GUD - Post by User

Knight Therapeutics Inc

Bullboard Posts

Comment by Benedict16thon Mar 15, 2020 8:32pm

63 Views

Post# 30810768

RE:RE:FED cuts interest rates to ZERO, launches $700 BILLION QE

I doubt a good start, hell fire is just starting for months till a vaccines wil be available for those over 65Y
Cash is king. Biotechs and techs companies and pipelines should be ok in the long term but the market will take time to separate the potential winners from the loosers. Expect Chaos volatility for months to come
I hope the JG fdinds real good deals outhere, but will he? I do not know. Are they overwelmed by the GBT takeover and be able to deal with new takeovers? ? I do not know. Time will tell

Bullboard Posts

Understanding different debt management strategies (good debt vs. bad debt)